These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 5340775)
1. The uptake and fate of isoniazid in Mycobacterium tuberculosis var. bovis BCG. Wimpenny JW J Gen Microbiol; 1967 Jun; 47(3):389-403. PubMed ID: 5340775 [No Abstract] [Full Text] [Related]
2. Effect of isoniazid on biosynthesis in Mycobacterium tuberculosis var. bovis BCG. Wimpenny JW J Gen Microbiol; 1967 Jun; 47(3):379-88. PubMed ID: 5340774 [No Abstract] [Full Text] [Related]
3. Metabolism of isoniazid by Mycobacterium tuberculosis BCG with reference to current theories of the mode of action. YOUATT J Am Rev Tuberc; 1958 Nov; 78(5):806-9. PubMed ID: 13583450 [No Abstract] [Full Text] [Related]
4. Selective effects of metabolic inhibitors on retinal cultures. Hansson HA Exp Eye Res; 1966 Oct; 5(4):335-54. PubMed ID: 5954525 [No Abstract] [Full Text] [Related]
5. An enzyme system of Mycobacterium tuberculosis that reacts specifically with isoniazid. II. Correlation of this reaction with the binding and metabolism of isoniazid. Youatt J; Tham SH Am Rev Respir Dis; 1969 Jul; 100(1):31-7. PubMed ID: 4978760 [No Abstract] [Full Text] [Related]
6. Mode of action of rifampin on mycobacteria. II. Biosynthetic studies on the inhibition of ribonucleic acid polymerase of Mycobacterium bovis BCG by rifampin and uptake of rifampin- 14 C by Mycobacterium phlei. Konno K; Oizumi K; Oka S Am Rev Respir Dis; 1973 Jun; 107(6):1006-12. PubMed ID: 4576356 [No Abstract] [Full Text] [Related]
7. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. Ramón-García S; Martín C; De Rossi E; Aínsa JA J Antimicrob Chemother; 2007 Mar; 59(3):544-7. PubMed ID: 17242035 [TBL] [Abstract][Full Text] [Related]
8. Enzymatic inactivation and reactivation of chloramphenicol by Mycobacterium tuberculosis and Mycobacterium bovis. Sohaskey CD FEMS Microbiol Lett; 2004 Nov; 240(2):187-92. PubMed ID: 15522506 [TBL] [Abstract][Full Text] [Related]
9. [The tricarboxylic acid cycle in attenuated Mycobacterium tuberculosis (BCG) and its variants resistant to streptomycin, PAS and isonicotinic acid hydrazide]. SORU E; ISTRATI M; SZABADOS J; TANASESCO D; PARASCHIVESCO M Arch Roum Pathol Exp Microbiol; 1961 Dec; 20():637-50. PubMed ID: 13915330 [No Abstract] [Full Text] [Related]
10. Studies on mycobacteria. II. The lipids of Mycobacterium tuberculosis var. BCG cultured on dextrose containing media. PORTELANCE V; PANISSET M Rev Can Biol; 1957 Apr; 16(1):112-23. PubMed ID: 13432350 [No Abstract] [Full Text] [Related]
11. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Ritz N; Tebruegge M; Connell TG; Sievers A; Robins-Browne R; Curtis N Antimicrob Agents Chemother; 2009 Jan; 53(1):316-8. PubMed ID: 18955515 [TBL] [Abstract][Full Text] [Related]
12. The effect of isoniazid on nicotinamide nucleotide levels in Mycobacterium bovis, strain BCG. Winder F; Collins P Am Rev Respir Dis; 1968 Apr; 97(4):719-20. PubMed ID: 4384559 [No Abstract] [Full Text] [Related]
13. [Asparagine metabolism in mycobacteria. I. Comparison of L-asparaginases obtained from BCG, M. fortuitum and M. phlei (author's transl)]. Andrejew A; Orfanelli MT; Desbordes J Ann Microbiol (Paris); 1974 Apr; 125A(3):323-39. PubMed ID: 4607580 [No Abstract] [Full Text] [Related]
14. The lipids of Mycobacterium tuberculosis BCG: fractionation, composition, turnover and the effects of isoniazid. Brennan PJ; Rooney SA; Winder FG Ir J Med Sci; 1970 Jun; 3(6):269-84. PubMed ID: 4988911 [No Abstract] [Full Text] [Related]
15. The accumulation and metabolism of dopamine by the human platelet. Solomon HM; Spirt NM; Abrams WB Clin Pharmacol Ther; 1970; 11(6):838-45. PubMed ID: 4394753 [No Abstract] [Full Text] [Related]
16. Isoniazid metabolism and binding by sensitive and resistant strains of Mycobacterium smegmatis. Fishbain D; Ling G; Kushner DJ Can J Microbiol; 1972 Jun; 18(6):783-92. PubMed ID: 5034223 [No Abstract] [Full Text] [Related]
18. Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer. Watts MR; Taylor PC; Sintchenko V; Whelan CM; Farnsworth RH; Jones P; Jelfs P; Carr D; Goldberg H Clin Infect Dis; 2011 Jan; 52(1):86-8. PubMed ID: 21148524 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors. Altaf M; Miller CH; Bellows DS; O'Toole R Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470 [TBL] [Abstract][Full Text] [Related]
20. [Studies on INH resistant BCG bacillus]. NAGATA S Kekkaku; 1958 Oct; 33(10):699-702; English abstract 707. PubMed ID: 13611846 [No Abstract] [Full Text] [Related] [Next] [New Search]